Table 2.
THC distribution differences and clinical characteristics of T1 - T3 breast cancer
| Clinical Stage | No. of Lesions | Age (Year) | Size (mm) | THC (μmol/L) | BMI | D1 (mm) | D2 (mm) | Ki67 |
|---|---|---|---|---|---|---|---|---|
| T1 | 148 | 53.5 ± 10.0⁎, # | 14.7 ± 3.4⁎, # | 181.6 ± 70.4⁎, # | 23.3 ± 2.8 | 7.4 ± 5.5 | 32.8 ± 17.1⁎, # | 27.1 ± 20.9⁎, # |
| T2 | 251 | 50.5 ± 10.0⁎ | 31.8 ± 8.2⁎ | 221.0 ± 56.0 | 23.5 ± 3.4 | 7.8 ± 11.1 | 24.8 ± 17.8⁎ | 39.7 ± 23.8 |
| T3 | 56 | 47.6 ± 11.1 | 61.1 ± 9.7 | 233.1 ± 54.0 | 23.7 ± 3.5 | 6.4 ± 3.4 | 14.0 ± 15.7 | 37.0 ± 22.6 |
| P value | 0.000 | 0.000 | 0.000 | 0.674 | 0.575 | 0.000 | 0.000 |
Note.—BMI:body mass index; THC:total hemoglobin concentration; D1:The distance from the lesion edge to the skin; D2; The distance from the lesion edge to the nipple;
⁎
:There were significant differences among T1 and T2 and T3;
#
:There were significant differences between T1 and T2.